News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Joins NHIA Future of Infusion Advisory Council
For Melinta, membership in the FIAC provides the opportunity for critical collaboration with the association and other organizations serving patients requiring infusion therapies. This work helps to enhance continuity of care as patients transition out of the hospital.
Melinta Therapeutics Announces Appointment Of Susan Blum As Chief Financial Officer
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel...
Melinta Therapeutics Announces FDA Approval of KIMYRSA™ (oritavancin)
The efficacy and safety of KIMYRSA were established in the SOLO clinical trials with another oritavancin product, ORBACTIV®...
Melinta Therapeutics Announces Appointment of John Harlow as Chief Commercial Officer
Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company focused on the development and commercialization of novel...